4finance Achieves 9.4 out of 10 eKomi Rating for Vivus Spain’s Single Payment Loans
28.6.2017 09:25:00 EEST | Business Wire | Press release
4finance Group S.A. (the “Group”), Europe’s largest online and mobile consumer lending group, has achieved a 9.4 eKomi rating in reviews of its Vivus.es single payment loan.
The Group is in the process of extending the use of consumer reviews to other consumer credit products and to other countries.
The Group, which recently reported that its registered online lending customers had grown to more than 6.3 million, will continue to gather direct, independent customer feedback to help develop its market leading proposition and customer service.
4finance brand vivus.es has already used feedback garnered from customer reviews to improve its service.
“We’re proud to say that nearly 97% of the reviews of our single payment loans have been positive,” said
Jose María García Casado, 4finance Spain’s country manager. “Enthusiastic feedback is welcome, but we have also learned how to improve our services and acted on feedback from customers.”
One example of the feedback being put into practice saw vivus.es adding more information on which banks are fastest to disburse its loans, in an effort to provide greater clarity to customers about when their loan will arrive. Most customers receive their loans in minutes.
“Customers know that eKomi is an independent, public forum to review and share their experiences - that helps us get direct feedback on the service we provide. Our use of eKomi’s reviews is a visible example of our commitment to transparent, convenient and responsible lending. Delivering Vivus customers a great experience is critical. Our customers are predominantly millennials, who increasingly manage and research their finances from their phones. Integrating customer reviews helps us better reflect the way our customers make decisions and to learn from our customers,” added Jose María García Casado.
4finance’s Danish Vivus operations, currently rated at 9.3 by Trustpilot, pioneered the use of consumer reviews with Trustpilot in 2012, shortly after opening for business. The team has used the feedback to continuously improve service, refine products, and to train and motivate the customer service team.
In Poland, Vivus.pl has been rated at 9.7 by customers on Trustpilot.
4finance offers consumer credit products to meet a range of needs, including single payment loans, line of credit and instalment. 4finance offers credit products that are a fast, convenient and responsible alternative to the established banks.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170627006625/en/
Contact information
4finance (Investor Relations)
James Etherington
Email: investorrelations@4finance.com
or
Guy
Middleton
Email: press@4finance.com
or
Instinctif
Partners (International Media)
Mark Walter/David Simonson
Email:
4finance@instinctif.com
+44
(0)20 7866 7887
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 15:00:00 EET | Press release
Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end workflows spanning onboarding, KYC, AML, fraud, underwriting, payments, disputes, servicing, and collections. For
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom